Therapeutic Potential of Cannabidiol – from Basic Concepts to Clinical studies

Cannabidiol (CBD) is a non-psychoactive compound derived from Cannabis sativa. It has a fascinating pharmacological profile, including a powerful anti-inflammatory action. It therefore has a lot of potential for use in diseases where inflammation is a key event. This free webinar will present the latest data on the anti-inflammatory mechanisms of CBD, results from pre-clinical and clinical studies and the pharmacokinetic and formulation challenges faced in its development as a therapeutic.

Themes and topic areas covered:
Mechanisms of anti-inflammatory effects of cannabidiol
Antifibrotic effects of cannabidiol
Role of inflammation in the anti-hypertensive effect of cannabidiol
CBD for the management of chronic chemotherapy-induced peripheral neuropathy
Pharmacokinetic and formulation challenges